Get the Stockscreener App
1.015
0.49%
-0.005
Cardiol Therapeutics Inc stock is traded at $1.015, with a volume of 359.55K.
It is down -0.49% in the last 24 hours and up +0.50% over the past month.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
See More
Previous Close:
$1.02
Open:
$1.02
24h Volume:
359.55K
Relative Volume:
0.66
Market Cap:
$101.50M
Revenue:
-
Net Income/Loss:
$-21.65M
P/E Ratio:
-3.0563
EPS:
-0.3321
Net Cash Flow:
$-15.84M
1W Performance:
+5.40%
1M Performance:
+0.50%
6M Performance:
-27.50%
1Y Performance:
-23.11%
1-Day Range:
$1.01
$1.045
1-Week Range:
$0.97
$1.08
52-Week Range:
$0.7709
$1.59
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.015 | 102.00M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
124.18 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.97 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.66 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
470.62 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jun-26-24 | Initiated | ROTH MKM | Buy |
| Apr-22-24 | Initiated | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Stock (CRDL) Latest News
Cardiol Therapeutics announces $13.5M bought-deal private placement - MSN
Will Cardiol Therapeutics Inc. (CT9) stock gain from lower interest ratesChart Pattern Recognition & Free Discover Fast Growing Stocks - bollywoodhelpline.com
Why Cardiol Therapeutics Inc. stock is favored by top institutionsCup and Handle Formations & Identify Breakout Stocks - bollywoodhelpline.com
Portfolio Shifts: Will Cardiol Therapeutics Inc outperform tech stocksTake Profit & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Cardiol Therapeutics announces $13.5 million private placement By Investing.com - Investing.com Nigeria
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics announces $13.5 million bought deal financing By Investing.com - Investing.com Nigeria
Cardiol Therapeutics Inc. announced that it expects to receive CAD 13.500001 million in funding - marketscreener.com
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs - TipRanks
Cardiol Therapeutics announces $13.5 million private placement - Investing.com
Cardiol Therapeutics announces $13.5 million bought deal financing - Investing.com
Heart drug developer Cardiol lines up $13.5M to fund trials and research - Stock Titan
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Yahoo Finance
AI Stocks: Is NeuroSense Therapeutics Ltd Equity Warrant forming a bullish divergenceJuly 2025 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.5% – Still a Buy? - Defense World
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.5%Still a Buy? - MarketBeat
(CRDL) On The My Stocks Page (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives $8.00 Consensus Price Target from Analysts - Defense World
Insider Sell: Is Cardiol Therapeutics Inc stock a safe investment in uncertain markets2025 EndofYear Setup & Consistent Return Strategy Ideas - Bộ Nội Vụ
Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial By Investing.com - Investing.com Nigeria
Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail
Cardiol Therapeutics Reaches 50% Enrollment in Pivotal Phase III MAVERIC Trial for Recurrent Pericarditis - TipRanks
Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial - Investing.com
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis - Investing News Network
Cardiol Therapeutics (NASDAQ: CRDL) reaches 50% MAVERIC Phase III enrollment - Stock Titan
Aug Movers: Can Cardiol Therapeutics Inc maintain its current growth rateJuly 2025 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn
Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long - Yahoo Finance
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
(CRDL) Stock Trading Blueprint (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics Reports Financial Challenges Amid Clinical Progress - MSN
What makes Cardiol Therapeutics Inc. stock attractive to growth fundsModel Comparison & lightweight options for faster days - Улправда
Why Cardiol Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 WrapUp & Fast Gain Stock Trading Tips - Улправда
Is Cardiol Therapeutics Inc. stock trading near support levelsAnalyst Downgrade & Advanced Technical Analysis Signals - Улправда
Aug Selloffs: Why Cardiol Therapeutics Inc. stock could benefit from AI revolutionPortfolio Risk Summary & High Conviction Buy Zone Alerts - Улправда
Is Cardiol Therapeutics Inc. (CT9) stock suitable for passive index fundsEarnings Beat & Reliable Breakout Forecasts - ulpravda.ru
Is Cardiol Therapeutics Inc. stock a buy on dipsBond Market & Community Trade Idea Sharing - Улправда
Can Cardiol Therapeutics Inc. (CT9) stock retain market dominanceShort Setup & Stock Portfolio Risk Management - ulpravda.ru
How Cardiol Therapeutics Inc. stock reacts to job market dataBuy Signal & AI Driven Stock Reports - Улправда
How institutional buying supports Cardiol Therapeutics Inc. stockLayoff News & High Return Stock Watch Alerts - Улправда
Is Cardiol Therapeutics Inc. stock attractive for growth ETFs2025 Short Interest & Growth-Oriented Investment Plans - ulpravda.ru
How Cardiol Therapeutics Inc. stock performs in weak economyLong Setup & AI Enhanced Trading Signals - Улправда
(CRDL) Technical Analysis and Trading Signals (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (NASDAQ:CRDL) Trading 1% HigherHere's What Happened - MarketBeat
SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference - Investing News Network
(CRDL) Strategic Market Analysis (CRDL:CA) - Stock Traders Daily
Cardiol Therapeutics (OTCMKTS:CRTPF) Stock Price Down 1.7% – Should You Sell? - Defense World
Learn to Evaluate (CRDL) using the Charts (CRDL:CA) - Stock Traders Daily
Movement Recap: Why Cardiol Therapeutics Inc stock could benefit from AI revolutionWeekly Risk Report & Risk Adjusted Swing Trade Ideas - moha.gov.vn
Trading (CRDL) With Integrated Risk Controls (CRDL:CA) - Stock Traders Daily
Cardiol TherapeuticsFinancial Details - Crunchbase
HC Wainwright & Co. Reiterates Cardiol Therapeutics (CRDL) Buy Recommendation - MSN
Cardiol Therapeutics Inc Stock (CRDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):